The Lung
暫譯: 肺部
El-Hashash, Ahmed
- 出版商: Academic Press
- 出版日期: 2021-06-15
- 售價: $6,320
- 貴賓價: 9.5 折 $6,004
- 語言: 英文
- 頁數: 174
- 裝訂: Quality Paper - also called trade paper
- ISBN: 0128212063
- ISBN-13: 9780128212066
海外代購書籍(需單獨結帳)
相關主題
商品描述
In the lung, more recent data have been accumulated on lung stem cell biology/function and the potential applications of stem cells in pulmonary diseases that are facilitated by the recent development of a broad range of cutting edge in vitro and in vivo research tools and approaches, including mouse and human organoid cultures, genetic editing in vitro and in vivo, human induced pluripotent cell (iPS cell) models of disease, haploid cells for genetic as well as compound screening paradigms, genetically engineered mice, and stem cell transplantation to cure diseases.
Stem Cell Innovation in Health and Disease: Volume 2: The Lung, contains two major sections describing cutting edge research for understanding stem cell functions in the lung and respiratory system, and for developing methods to bring stem cells from bench to bedside; respectively. Each section includes insights ranging from using mouse and human organoid cultures, genetic editing in vitro and in vivo, and human induced pluripotent cells (iPSCs) to study stem cell functions and model lung diseases, through the cutting-edge research aiming to bring stem cells from bench to bedside, including the potential application of iPSCs, ESCs and blood stem cells (stem cell transplants) in the treatment of lung diseases/disorders. This book, therefore, discusses the fact-based promise of stem cells and regenerative medicine in the lung in the real world.
商品描述(中文翻譯)
在肺部,最近的數據已經累積了有關肺幹細胞生物學/功能以及幹細胞在肺部疾病中的潛在應用,這得益於一系列尖端的體外和體內研究工具和方法的發展,包括小鼠和人類類器官培養、體外和體內的基因編輯、人類誘導多能幹細胞(iPS細胞)疾病模型、單倍體細胞用於基因及化合物篩選範式、基因工程小鼠,以及幹細胞移植以治療疾病。
《健康與疾病中的幹細胞創新:第二卷:肺部》包含兩個主要部分,分別描述了理解肺部和呼吸系統中幹細胞功能的尖端研究,以及開發將幹細胞從實驗室轉化到臨床的方法。每個部分都包括從使用小鼠和人類類器官培養、體外和體內的基因編輯,以及人類誘導多能幹細胞(iPSCs)來研究幹細胞功能和模擬肺部疾病的見解,直到旨在將幹細胞從實驗室轉化到臨床的尖端研究,包括iPSCs、胚胎幹細胞(ESCs)和血液幹細胞(幹細胞移植)在治療肺部疾病/障礙中的潛在應用。因此,本書討論了幹細胞和再生醫學在肺部的基於事實的前景。